March 9, 2026
Nutrition quality should be prioritized over restriction, especially in patients using GLP-1 therapies
Acknowledgements Support for VA and Centers for Medicare and Medicaid Services data is provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (Project Number/Data Use Agreement ID Al-Aly-01-A-1)
By helping people limit compulsive eating and drinking, motivate movement, and reduce chronic inflammation, which we know GLP-1s can do, we promote a higher quality life. The latest science demonstrates that we should be thinking about GLP-1 medication differently, said Dr
Due to IR, the brain cannot use glucose, thus leading to inflammation and the deposition of plaques and tangles (43)
From 2013 to 2016, 23% of T2D patients in the US received DPP4i, and 6% of patients received GLP-1-RA [7]